Abstract
Neuroinflammation is a major contributor to bilirubin-induced neurotoxicity, which results in severe neurological deficits. Microglia are the primary immune cells in the brain, with M1 microglia promoting inflammatory injury and M2 microglia inhibiting neuroinflammation. Controlling microglial inflammation could be a promising therapeutic strategy for reducing bilirubin-induced neurotoxicity. Primary microglial cultures were prepared from 1–3-day-old rats. In the early stages of bilirubin treatment, pro-/anti-inflammatory (M1/M2) microglia mixed polarization was observed. In the late stages, bilirubin persistence induced dominant proinflammatory microglia, forming an inflammatory microenvironment and inducing iNOS expression as well as the release of tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1β. Simultaneously, nuclear factor-kappa B (NF-κB) was activated and translocated into the nucleus, upregulating inflammatory target genes. As well known, neuroinflammation can have an effect on N-methyl-D-aspartate receptor (NMDAR) expression or function, which is linked to cognition. Treatment with bilirubin-treated microglia-conditioned medium did affect the expression of IL-1β, NMDA receptor subunit 2A (NR2A), and NMDA receptor subunit 2B (NR2B) in neurons. However, VX-765 effectively reduces the levels of proinflammatory cytokines TNF-α, IL-6, and IL-1β, as well as the expressions of CD86, and increases the expressions of anti-inflammatory related Arg-1. A timely reduction in proinflammatory microglia could protect against bilirubin-induced neurotoxicity.
Similar content being viewed by others
Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Balzano T, Dadsetan S, Forteza J et al (2019) Chronic hyperammonemia induces peripheral inflammation that leads to cognitive impairment in rats: reversal by anti-TNFa treatment. J Hepatol
Brewer GJ, Torricelli JR, Evege EK, Price PJ (1993) Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J Neurosci Res 35(5):567–576
Brites D (2012) The evolving landscape of neurotoxicity by unconjugated bilirubin: role of glial cells and inflammation. Front Pharmacol 3:88
Brites D, Fernandes A, Falcão AS, Gordo AC, Silva RF, Brito MA (2009) Biological risks for neurological abnormalities associated with hyperbilirubinemia. J Perinatol 29(Suppl 1):S8-13
Brito MA, Vaz AR, Silva SL et al (2010) N-methyl-aspartate receptor and neuronal nitric oxide synthase activation mediate bilirubin-induced neurotoxicity. Mol Med 16(9–10):372–380
Costa C, Sgobio C, Siliquini S et al (2012) Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson’s disease. Brain 135(Pt 6):1884–1899
Cull-Candy SG, Leszkiewicz DN (2004) Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 2004(255):re16
Fink SL, Cookson BT (2006) Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol 8(11):1812–1825
Ganbold T, Bao Q, Zandan J, Hasi A, Baigude H (2020) Modulation of microglia polarization through silencing of NF-κB p65 by functionalized curdlan nanoparticle-mediated RNAi. ACS Appl Mater Interfaces 12(10):11363–11374
Huang H, He C, Li S, Zhang Y, Hua Z (2020) Role of pyroptosis in bilirubin-induced microglial injury. Zhongguo Dang Dai Er Ke Za Zhi 22:1027–1033 (in Chinese)
Jin WN, Shi SX, Li Z et al (2017) Depletion of microglia exacerbates postischemic inflammation and brain injury. J Cereb Blood Flow Metab 37(6):2224–2236
Jolivel V, Brun S, Binamé F et al (2021) Microglial cell morphology and phagocytic activity are critically regulated by the neurosteroid allopregnanolone: a possible role in neuroprotection. Cells 10(3)
Kabba JA, Xu Y, Christian H et al (2018) Microglia: housekeeper of the central nervous system. Cell Mol Neurobiol 38(1):53–71
Kalkman HO, Feuerbach D (2016) Antidepressant therapies inhibit inflammation and microglial M1-polarization. Pharmacol Ther 163:82–93
Lalancette-Hébert M, Gowing G, Simard A, Weng YC, Kriz J (2007) Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 27(10):2596–2605
Lau CG, Zukin RS (2007) NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 8(6):413–426
Lee DJ, Du F, Chen SW et al (2015) Regulation and function of the caspase-1 in an inflammatory microenvironment. J Invest Dermatol 135(8):2012–2020
Li M, Song S, Li S, Feng J, Hua Z (2015) The blockade of NF-κB activation by a specific inhibitory peptide has a strong neuroprotective role in a Sprague-Dawley rat kernicterus model. J Biol Chem 290(50):30042–30052
Li S, Huang H, Wei Q et al (2021) Depression of pyroptosis by inhibiting caspase-1 activation improves neurological outcomes of kernicterus model rats. ACS Chem Neurosci 12(15):2929–2939
Li S, Huang H, Zhang Y, Li L, Hua Z (2022) Bilirubin induces A1-like reactivity of astrocyte. Neurochem Res
Liu Z, Gan L, Xu Y et al (2017) Melatonin alleviates inflammasome-induced pyroptosis through inhibiting NF-κB/GSDMD signal in mice adipose tissue. J Pineal Res 63(1)
May MJ, D’Acquisto F, Madge LA, Glöckner J, Pober JS, Ghosh S (2000) Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 289(5484):1550–1554
McKenzie BA, Dixit VM, Power C (2020) Fiery cell death: pyroptosis in the central nervous system. Trends Neurosci 43(1):55–73
Mejia GB, Sanz CR, Avila MM, Peraza AV, Guzmán DC, Olguín HJ, Ramírez AM, Cruz EG (2008) Experimental hemolysis model to study bilirubin encephalopathy in rat brain. J Neurosci Methods 168(1):35–41
Memon N, Weinberger BI, Hegyi T, Aleksunes LM (2016) Inherited disorders of bilirubin clearance. Pediatr Res 79(3):378–386
Même W, Calvo CF, Froger N et al (2006) Proinflammatory cytokines released from microglia inhibit gap junctions in astrocytes: potentiation by beta-amyloid. FASEB J 20(3):494–496
Nakagawa Y, Chiba K (2015) Diversity and plasticity of microglial cells in psychiatric and neurological disorders. Pharmacol Ther 154:21–35
Napoli I, Neumann H (2009) Microglial clearance function in health and disease. Neuroscience 158(3):1030–1038
Pahl HL (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18(49):6853–6866
Perry VH, Holmes C (2014) Microglial priming in neurodegenerative disease. Nat Rev Neurol 10(4):217–224
Phani S, Loike JD, Przedborski S (2012) Neurodegeneration and inflammation in Parkinson’s disease. Parkinsonism Relat Disord 18(Suppl 1):S207–S209
Pranty AI, Shumka S, Adjaye J (2022) Bilirubin-induced neurological damage: current and emerging iPSC-derived brain organoid models. Cells 11(17)
Rajendrakumar SK, Revuri V, Samidurai M et al (2018) Peroxidase-mimicking nanoassembly mitigates lipopolysaccharide-induced endotoxemia and cognitive damage in the brain by impeding inflammatory signaling in macrophages. Nano Lett 18(10):6417–6426
Reemst K, Noctor SC, Lucassen PJ, Hol EM (2016) The indispensable roles of microglia and astrocytes during brain development. Front Hum Neurosci 10:566
Rice AC, Shapiro SM (2008) A new animal model of hemolytic hyperbilirubinemia-induced bilirubin encephalopathy (kernicterus). Pediatr Res 64(3):265–269
Schiavon E, Smalley JL, Newton S, Greig NH, Forsythe ID (2018) Neuroinflammation and ER-stress are key mechanisms of acute bilirubin toxicity and hearing loss in a mouse model. PLoS ONE 13(8):e0201022
Shi J, Zhao Y, Wang K et al (2015) Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526(7575):660–665
Shih RH, Wang CY, Yang CM (2015) NF-kappaB signaling pathways in neurological inflammation: a mini review. Front Mol Neurosci 8:77
Silva SL et al (2012) Neuritic growth impairment and cell death by unconjugated bilirubin is mediated by NO and glutamate, modulated by microglia, and prevented by glycoursodeoxycholic acid and interleukin-10. Neuropharmacology 62:2398–2408. https://doi.org/10.1016/j.neuropharm.2012.02.002
Ślusarczyk J, Trojan E, Głombik K et al (2018) Targeting the NLRP3 inflammasome-related pathways via tianeptine treatment-suppressed microglia polarization to the M1 phenotype in lipopolysaccharide-stimulated cultures. Int J Mol Sci 19(7)
Song GJ, Suk K (2017) Pharmacological modulation of functional phenotypes of microglia in neurodegenerative diseases. Front Aging Neurosci 9:139
Tamashiro TT, Dalgard CL, Byrnes KR (2012) Primary microglia isolation from mixed glial cell cultures of neonatal rat brain tissue. J Vis Exp 66:e3814
Tang Y, Le W (2016) Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol Neurobiol 53(2):1181–1194
Watchko JF, Tiribelli C (2013) Bilirubin-induced neurologic damage–mechanisms and management approaches. N Engl J Med 369(21):2021–2030
Weinhard L, di Bartolomei G, Bolasco G et al (2018) Microglia remodel synapses by presynaptic trogocytosis and spine head filopodia induction. Nat Commun 9(1):1228
Wu Y, Dissing-Olesen L, MacVicar BA, Stevens B (2015) Microglia: dynamic mediators of synapse development and plasticity. Trends Immunol 36(10):605–613
Wyllie DJ, Livesey MR, Hardingham GE (2013) Influence of GluN2 subunit identity on NMDA receptor function. Neuropharmacology 74:4–17
Zhang C, Griciuc A, Hudry E et al (2018) Cromolyn reduces levels of the Alzheimer’s disease-associated amyloid β-protein by promoting microglial phagocytosis. Sci Rep 8(1):1144
Acknowledgements
The authors thank Tan Bin and Meng Shasha for the excellent technical assistance.
Funding
This work was supported by the National Natural Science Foundation (81971426) and the Postgraduate Research Innovation Project of Chongqing (Grant CYB22213).
Author information
Authors and Affiliations
Contributions
Ziyu Hua and Hongmei Huang participated in the design of this study, and they both performed the statistical analysis. Ziyu Hua carried out the study and collected important background information. Hongmei Huang performed the investigation, data collection, and data analysis and drafted the original manuscript. All authors read and approved the final manuscript. Siyu Li and Chunmei He carried out the methodology, literature search, data acquisition, data analysis, and manuscript preparation. Yan Zhang provided assistance for resources, data acquisition, data analysis, and statistical analysis. Ziyu Hua and Yan Zhang performed manuscript review. All authors have read and approved the content of the manuscript.
Corresponding author
Ethics declarations
Ethics Approval
Rats were purchased from Experimental Animal Center of Chongqing Medical University (License No. SYXK Chongqing 2018–0003), and the experimental process was strictly in accordance with the Chinese Measures for the Use and Management of Experimental Animals.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Huang, H., Li, S., Zhang, Y. et al. Microglial Priming in Bilirubin-Induced Neurotoxicity. Neurotox Res 41, 338–348 (2023). https://doi.org/10.1007/s12640-023-00643-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-023-00643-6